Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Satoris Enters Collaboration to Validate Early Alzheimer's Test
April 18th, 2008
Satoris, Inc., a molecular diagnostics company focused on developing blood-based tests for Alzheimer's disease, will shortly begin a collaborative study with the Mayo Foundation for Medical Education and Research (Mayo Clinic) to validate the utility of plasma biomarkers for early detection of mild to moderate Alzheimer's disease. These biomarkers may also predict the progression of patients from a state of mild cognitive impairment to Alzheimer's. Satoris researchers first reported the utility of Alzheimer's-related biomarkers in the November, 2007 edition of the peer-reviewed scientific journal, Nature Medicine. In the reported study, researchers analyzed 259 stored...
Source: Health Business Week (2008-04-18)
|
